Current Litigation

Military members exposed to dangerously high level of sound.

3M 0—1 in Earplugs Test Cases

by Leah Rush Easterby Contributing Editor 3M Products Liability Litigation MDL 2885 Combat Arms Aren’t Your Typical Earplugs 3M’s Combat Arms are dual-ended earplugs designed for one side to block all noise and the other to be transparent enough to hear voice commands while blocking harmful ballistic noises. U.S. soldiers used the earplugs in Iraq, […]

Zantac Litigation Overview

Article Provided by Brenden Leydon Attorney at Wocl Leydon LLC The litigation over the harmful effects of Zantac (generic name is Ranitidine) is just getting underway, and it looks like it will lead to a significant number of cases. What is Zantac/Ranitidine? Ranitidine is an antacid which belongs to a class of drugs known as histamine-2 […]

Nuedexta: Drug Being Pushed “Off-Label” On Elderly In Nursing Homes = $116 Million Settlement

Avanir Pharmaceuticals, the maker of Nuedexta, a prescription drug approved to treat a rare neurological condition is earning hundreds of millions of dollars a year  by aggressively targeting elderly nursing home residents in “off-label” use, for whom the drug may be unnecessary and now recognized as unsafe. Off-label use is when a company offers and […]

JUUL: How Big Tobacco bought into a company that killed teens for profit!

The FDA missed a deadly corporate marketing campaign–AGAIN! Juul’s popularity was fueled by the company’s social media marketing that featured attractive young people in fun, trendy settings. A report by Stanford University researchers concluded that Juul’s launch marketing was “patently youth oriented” and “subsequently Juul’s principal advertising themes have been closely aligned with that of traditional tobacco advertising.” Why […]

Why Does the FDA Ignore “Off-Label” Drug Marketing While Thousands Die Every Year?

Profits Before Patients is the FDA-Big Pharma Shared Model “BY REMOVING FDA OVERSIGHT BIG PHARMA WAS ALLOWED TO PROFIT FROM LIES” (October 19, 2019) (MASS TORT NEWS)  Starting in 2017 and continuing into the foreseeable future, Big Pharma has been fighting major legal battles related to off-label marketing of drugs for unintended uses. They also […]